弗鲁金丁尼布诱导的脏有限的血栓性微血管病变:一个病例报告
Ruiping Zhao1, Ruichen Fan2, Yan Pan1
1Department of Nephrology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
BMC nephrology
|May 18, 2024
概括
弗鲁昆丁尼布是一种VEGFR抑制剂,可能导致脏限制性血栓性微血管病变 (TMA),这是罕见的癌症治疗并发症. 通过蛋白尿监测和活检进行早期检测对于接受抗VEGF治疗的患者至关重要.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 弗鲁昆丁尼布是一种选择性血管内皮生长因子受体 (VEGFR) 抑制剂,用于癌症治疗.
- 之前没有报告将弗鲁昆丁尼布与脏限制性血栓性微血管病变 (TMA) 联系起来.
相关概念视频
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...


